Here you can find the latest news and updates from EUCAST.

20 Feb 2023
Updated files demonstrating the correlation between MIC and inhibition zone diameters.

Files demonstrating the correlation between MIC-values and EUCAST standardised disk diffusion inhibition zone diameters are updated yearly. The 2023 update is now completed. New for this year are files for Vibrio spp. andC....[more]

18 Feb 2023
Br. melitensis and B. anthracis - MIC and zone diameter distributions available

EUCAST will during 2023, based on the work of theEMERGE AST Working Group, strive to publish clinical breakpoints and disk diffusion correlates for Brucella melitensis and Bacillus anthracis. Through the joint effort of the...[more]

18 Feb 2023
EUCAST General Committee meeting Monday 17 April, 2023.

EUCAST General Committee meeting will be held during ECCMID, Copenhagen, Monday 17 April, 9.30 - 10.30, Room 178 (1st Floor Hotel). This is an open meeting and there is no pre-registration. A reminder and an agenda will be...[more]

17 Feb 2023

EUCAST has prepared a statement in response to questions related to how the IVDR will affect users of EUCAST methods and guidance. The statement and a link to the directive are available...[more]

10 Feb 2023
Consultation on clinical breakpoints for anaerobic bacteria - additional agents.

EUCAST has so far included five species/species groups in the breakpoint table for anaerobic bacteria; Bacteroides, Prevotella spp, Fusobacterium necrophorum, Clostridium perfringens and Cutibacterium acnes. This general...[more]

08 Feb 2023
Fosfomycin IV - EUCAST comments and response to consultation

Fosfomycin IV - EUCAST response to the many comments on the fosfomycin consultation during 2022. [more]

08 Feb 2023
The use of cefotaxime and ceftriaxone in S. aureus infections - guidance document

The use of cefotaxime and ceftriaxone in infections caused byS. aureus- a new guidance document. [more]

Displaying results 8 to 14 out of 500